Axis-Clinical Software vs Hydra: Revenue, Funding & Team Size Compared
Axis-Clinical Software generates $3.7M in revenue; Hydra generates $3.8M. Hydra and Axis-Clinical Software are close to the same size by revenue. The table below compares Axis-Clinical Software and Hydra on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $3.7M | $3.8M |
| Valuation | $30M | Not disclosed |
| Team size | 19 | 25 |
| Founded | 1980 | 2021 |
| HQ | Portland, United States | San Francisco, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Axis-Clinical Software at a glance
Axis-Clinical Software generates $3.7M in revenue with 19 employees, headquartered in Portland, United States.
- Revenue
- $3.7M
- Valuation
- $30M
- Team size
- 19
- Founded
- 1980
Axis Clinical Software, Inc. Innovative software solutions for managing clinical data, registry participation, and for facilitating sound decisions and better care, all things that ultimately reduce costs and improve outcomes.
Hydra at a glance
Hydra generates $3.8M in revenue with 25 employees, headquartered in San Francisco, United States.
- Revenue
- $3.8M
- Team size
- 25
- Founded
- 2021
DuckDB-Powered Postgres for real-time apps and analytics.
Other Axis-Clinical Software alternatives
Axis-Clinical Software competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Axis-Clinical Software vs Hydra: frequently asked questions
Is Axis-Clinical Software or Hydra bigger?
Hydra is the bigger company by revenue, at $3.8M against $3.7M for Axis-Clinical Software.
How much revenue does Axis-Clinical Software make?
Axis-Clinical Software generates $3.7M in annual revenue with a team of 19.
How much revenue does Hydra make?
Hydra generates $3.8M in annual revenue with a team of 25.